Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Deloitte
Chubb
Healthtrust
Cantor Fitzgerald
Teva
Merck
Citi
McKinsey
McKesson

Generated: October 23, 2017

DrugPatentWatch Database Preview

Patents Expiring in September 2033

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Eagle Pharms
DOCETAXEL
docetaxel
SOLUTION;IV (INFUSION)205934-003Dec 22, 2015RXNoNo► Subscribe► SubscribeY
Eagle Pharms
DOCETAXEL
docetaxel
SOLUTION;IV (INFUSION)205934-003Dec 22, 2015RXNoNo► Subscribe► SubscribeY METHOD OF ADMINISTERING AN ETHANOL-FREE TAXANE LIQUID NANODISPERSION FORMULATION TO A SUBJECT COMBINING THE FORMULATION WITH AN AQUEOUS MEDIUM TO PROVIDE AN ETHANOL-FREE TAXANE DILUTED SOLUTION
Eagle Pharms
DOCETAXEL
docetaxel
SOLUTION;IV (INFUSION)205934-002Dec 22, 2015RXNoNo► Subscribe► SubscribeY
Eagle Pharms
DOCETAXEL
docetaxel
SOLUTION;IV (INFUSION)205934-002Dec 22, 2015RXNoNo► Subscribe► SubscribeY METHOD OF ADMINISTERING AN ETHANOL-FREE TAXANE LIQUID NANODISPERSION FORMULATION TO A SUBJECT COMBINING THE FORMULATION WITH AN AQUEOUS MEDIUM TO PROVIDE AN ETHANOL-FREE TAXANE DILUTED SOLUTION
Eagle Pharms
DOCETAXEL
docetaxel
SOLUTION;IV (INFUSION)205934-001Dec 22, 2015RXNoNo► Subscribe► SubscribeY
Eagle Pharms
DOCETAXEL
docetaxel
SOLUTION;IV (INFUSION)205934-001Dec 22, 2015RXNoNo► Subscribe► SubscribeY METHOD OF ADMINISTERING AN ETHANOL-FREE TAXANE LIQUID NANODISPERSION FORMULATION TO A SUBJECT COMBINING THE FORMULATION WITH AN AQUEOUS MEDIUM TO PROVIDE AN ETHANOL-FREE TAXANE DILUTED SOLUTION
Cardinal Health 414
LYMPHOSEEK KIT
technetium tc-99m tilmanocept
INJECTABLE;INJECTION202207-001Mar 13, 2013RXYesYes► Subscribe► SubscribeYY
Teva Branded Pharm
AUSTEDO
deutetrabenazine
TABLET;ORAL208082-002Apr 3, 2017RXYesNo► Subscribe► SubscribeYY TREATMENT OF A NEURODEGENERATIVE DISEASE OR A SYMPTOM THEREOF
Teva Branded Pharm
AUSTEDO
deutetrabenazine
TABLET;ORAL208082-001Apr 3, 2017RXYesNo► Subscribe► SubscribeY
Teva Branded Pharm
AUSTEDO
deutetrabenazine
TABLET;ORAL208082-001Apr 3, 2017RXYesNo► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Cerilliant
Baxter
Chubb
Farmers Insurance
Covington
Dow
Daiichi Sankyo
Federal Trade Commission
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot